CAS: 1191450-19-7
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Burixafor hydrobromide REF: 3D-RXB45019CAS: 1191450-19-7 | Min. 95% | To inquire | Tue 27 May 25 |
 | Burixafor hydrobromide REF: TM-T10635CAS: 1191450-19-7 | 98% | To inquire | Mon 02 Jun 25 |
Burixafor hydrobromide
CAS:1191450-19-7
Please enquire for more information about Burixafor hydrobromide including the price, delivery time and more …
Formula:
C27H60Br3N8O6P
Purity:
Min. 95%
Molecular weight:
863.5 g/mol
Ref: 3D-RXB45019
| 100mg | 963.00 € |
Estimated delivery in United States, on Tuesday 27 May 2025
Burixafor hydrobromide
CAS:1191450-19-7
Burixafor hydrobromide is an oral CXCR4 blocker with anti-angiogenic properties, potentially treating choroid neovascularization.
Formula:
C27H52BrN8O3P
Purity:
98%
Color and Shape:
Solid
Molecular weight:
647.644
Ref: TM-T10635
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 2 Jun 2025
